Quinn Patrick L, McAlearney Ann Scheck, Eramo Jennifer, Chen Sadie, Cloyd Jordan M, Rush Laura J, Ejaz Aslam
The Ohio State University Wexner Medical Center, Columbus, OH, USA.
University of Illinois Chicago, Chicago, IL, USA.
Support Care Cancer. 2025 Aug 30;33(9):825. doi: 10.1007/s00520-025-09878-9.
Informed decision-making is an essential component of shared decision-making between patients and their cancer teams that promotes patient comprehension of their disease and available treatment options. The complex nature of multidisciplinary treatment for pancreatic cancer (PC) presents unique challenges for informed decision-making, for which barriers and facilitators are poorly understood.
In this qualitative study, semi-structured interviews were conducted with PC patients seeking treatment at a Midwestern, high-volume, academic medical center to examine various aspects of informed decision-making, including patients' understanding of treatment options, challenges in obtaining information, and how a decision aid may improve decision-making. Purposive sampling was used for recruitment and continued until thematic saturation was achieved. All interviews were audio-recorded, transcribed, and coded by the research team. Qualitative analysis was completed using an integrative approach involving both inductive and deductive methods.
Across 20 PC patients interviewed, the median age was 67 years, with 30% having metastatic disease (n = 6). Most patients reported having a knowledge gap about PC treatment options, requiring them to explore multiple resources to support their treatment decision-making. Furthermore, most interviewees noted that additional information in the form of a decision aid could be helpful in their decision-making process, particularly in understanding the advantages and disadvantages of treatment options, but also in introducing supportive care resources and improving their understanding of palliative care. However, concerns regarding the potential for providing too much information at once were common and perceived as potentially overwhelming.
This qualitative study highlights the challenges that PC patients face in making informed treatment decisions and, therefore, in engaging in shared decision-making. Further research on patient-centered strategies, such as decision aids, is needed to improve the quality of both shared and informed decision-making.
知情决策是患者与其癌症治疗团队共同决策的重要组成部分,有助于患者理解自身疾病及可用的治疗方案。胰腺癌(PC)多学科治疗的复杂性给知情决策带来了独特挑战,对此,阻碍因素和促进因素尚不清楚。
在这项定性研究中,对在中西部一家大型学术医疗中心寻求治疗的PC患者进行了半结构式访谈,以考察知情决策的各个方面,包括患者对治疗方案的理解、获取信息的挑战以及决策辅助工具如何改善决策。采用目的抽样法进行招募,持续进行直至达到主题饱和。所有访谈均进行了录音、转录并由研究团队编码。使用归纳和演绎相结合的综合方法完成定性分析。
在接受访谈的20名PC患者中,中位年龄为67岁,30%(n = 6)患有转移性疾病。大多数患者报告称对PC治疗方案存在知识缺口,这就要求他们探索多种资源来支持其治疗决策。此外,大多数受访者指出,决策辅助工具形式的额外信息在其决策过程中可能会有所帮助,特别是在理解治疗方案的优缺点方面,而且在介绍支持性护理资源和增进他们对姑息治疗的理解方面也有帮助。然而,对一次性提供过多信息的担忧很常见,且被认为可能会让人应接不暇。
这项定性研究突出了PC患者在做出知情治疗决策以及参与共同决策时所面临的挑战。需要对以患者为中心的策略(如决策辅助工具)进行进一步研究,以提高共同决策和知情决策的质量。